Advances in the Management and Treatment of Dry Eye Disease

Ophthalmologist experts provide an overview of dry eye disease.

Laura Periman, MD, discusses the prevalence and risk factors of dry eye disease.

Brandon Ayres, MD, discusses the pathophysiology of dry eye disease related to obstruction and inflammation.

Eric Donnenfeld, MD, discusses initiating treatment for dry eye disease.

Experts provide an overview of the diagnostic process for identifying dry eye disease.

Experts discuss diagnosing meibomian gland dysfunction (MGD), the most common cause of dry eye disease.

Kendall Donaldson, MD, MS, and I. Paul Singh, MD, describe the first-line approach to treating dry eye disease.

Eric Donnenfeld, MD, provides an overview of different anti-inflammatory agents treatment options for dry eye disease.

Laura Periman, MD, describes the mechanism of action of lifitegrast for the treatment of dry eye disease.

Brandon Ayres, MD, provides an overview of lifitegrast efficacy and safety from the OPUS trials for the treatment of dry eye disease.

Experts discuss data from the OPUS trials for the treatment of dry eye disease.

Ophthalmologist experts discuss the rationale for choosing specific treatments for dry eye disease.

Laura Periman, MD, describes different procedural therapies for the treatment of dry eye disease.

Experts discuss managing patients with overlapping eye diseases that require concurrent treatment, including before cataract and refractive surgery.

Ophthalmologist experts discuss treating patients with dry eye disease who wear contacts.

Ophthalmologist experts provide an overview of emerging treatments for dry eye disease.